Recombinant Human alpha-L-Iduronidase/IDUA Protein, CF
Recombinant Human alpha-L-Iduronidase/IDUA Protein, CF Summary
Product Specifications
Ala26-Pro653 (Ala26Thr), with a C-terminal 10-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
4119-GH
| Formulation | Supplied as a 0.2 μm filtered solution in Sodium Acetate, NaCl and Glycerol. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Assay Procedure
- Assay Buffer: 50 mM NaOAc, 150 mM NaCl, 0.02% Brij-35 (w/v) pH 3.5
- Developing Buffer: 0.1 M Tris, pH 9.0
- Recombinant Human alpha ‑L‑Iduronidase/IDUA (rhIDUA) (Catalog # 4119-GH)
- Substrate: 4-methylumberlliferyl-alpha -L-iduronide (Glycosynth, Catalog # 44076), 20 mM stock in DMSO
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Dilute rhIDUA to 0.2 µg/mL in Assay Buffer. Minimize the number of dilution steps to obtain the best activity results.
- Dilute Substrate to 200 µM in Assay Buffer.
- Combine equal volumes of 0.2 µg/mL rhIDUA and 200 µM Substrate. Include a Substrate Blank containing Assay Buffer and Substrate.
- Incubate for 10 minutes at room temperature.
- Dilute mixtures to 0.005 µg/mL in Developing Buffer.
- Load 100 µL of the diluted mixtures into a plate.
- Read at excitation and emission wavelengths of 365 nm and 445 nm (top read), respectively in endpoint mode.
- Calculate specific activity:
|
Specific Activity (pmol/min/µg) = |
Adjusted Fluorescence* (RFU) x Conversion Factor** (pmol/RFU) |
| Incubation time (min) x amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard 4-methylumbelliferone (Sigma, Catalog # M1381).
Per Well:- rhIDUA: 0.0005 µg
- Substrate: 5 µM
Scientific Data
View Larger
Recombinant Human alpha-L-Iduronidase/IDUA Protein, CF (Catalog # 4119-GH) hydrolyzes iduronic acid from dermatan and heparan sulfates.
View Larger
Recombinant Human alpha-L-Iduronidase/IDUA Protein, CF (Catalog # 4119-GH) is measured by its ability to cleave a fluorogenic substrate, 4-Methylumbelliferyl alpha -L-iduronide.
View Larger
2 μg/lane of Recombinant Human alpha-L-Iduronidase / IDUA Protein (Catalog # 4119-GH) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing a band at ~83 kDa under reducing conditions.
Reconstitution Calculator
Background: alpha-L-Iduronidase/IDUA
alpha -L-Iduronidase encoded by the IDUA gene is an important enzyme required for the lysosomal degradation of glycosaminoglycans (GAGs). It hydrolyzes the non‑reducing terminal alpha -L-iduronic acid residues in GAGs including dermatan sulfate and heparan sulfate. Mutations in IDUA that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I) (1). MPS I causes progressive cellular, tissue and organ damage, and several clinical studies using enzyme replacement therapy have shown promising benefits (2).
Citations for Recombinant Human alpha-L-Iduronidase/IDUA Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
3
Citations: Showing 1 - 3
Filter your results:
Filter by:
-
Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome
Authors: K Laoharawee, KM Podetz-Ped, TT Nguyen, SM Singh, MC Smith, LR Belur, WC Low, KF Kozarsky, RS McIvor
Molecular genetics and metabolism reports, 2023-01-20;34(0):100956.
Species: Mouse
Sample Types: Tissue Homogenates
Applications: Bioassay -
Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II
Authors: Y Osaki, A Saito, S Kanemoto, M Kaneko, K Matsuhisa, R Asada, T Masaki, K Orii, T Fukao, S Tomatsu, K Imaizumi
Cell Death Dis, 2018-07-24;9(8):808.
Species: Human
Sample Types: Whole Cells
Applications: Enzyme Assay -
Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In�Vivo Genome Editing
Authors: K Laoharawee, RC DeKelver, KM Podetz-Ped, M Rohde, S Sproul, HO Nguyen, T Nguyen, SJ St Martin, L Ou, S Tom, R Radeke, KE Meyer, MC Holmes, CB Whitley, T Wechsler, RS McIvor
Mol. Ther., 2018-03-10;26(4):1127-1136.
Species: Mouse
Sample Types: Tissue Homogenates
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human alpha-L-Iduronidase/IDUA Protein, CF
Average Rating: 5 (Based on 1 Review)
Have you used Recombinant Human alpha-L-Iduronidase/IDUA Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
